TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7208632

Group type: EXPERIMENTAL
Intervention: Asymmetric tonic neck reflex with active head rotation toward the extending wrist
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Asymmetric tonic neck reflex with active head rotation away from the extending wrist
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: High-frequency muscle vibration with head in neutral position
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination of active head rotation toward the extending wrist and vibration of the extensor surface
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control groups (fatigue, experimental learning, weight of vibrator)
Number of subjects: 150
Study: 11772809

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.25%
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution)
Number of subjects: 37
Study: 30213747

Group type: EXPERIMENTAL
Intervention: Food-specific response inhibition training (active group)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Response inhibition training without food stimuli (control group)
Number of subjects: 41
Study: 26652904

Group type: EXPERIMENTAL
Intervention: Transdermal 17β‐estradiol (tE2)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogens (oCEE)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 79
Study: 24661479

Group type: EXPERIMENTAL
Intervention: Therapeutic suggestion (TS)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Noise recordings (Control)
Number of subjects: 94
Study: 22664557

Group type: EXPERIMENTAL
Intervention: Comprehensive training curriculum for laparoscopic colorectal surgery
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional residency training
Number of subjects: 25
Study: 19675958

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy
Number of subjects: 34
Study: 18587579

Group type: EXPERIMENTAL
Intervention: Bolus etoposide
Number of subjects: 47

Group type: COMPARATOR
Intervention: Continuous infusion etoposide
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: CEMP regimen (cisplatinum, etoposide, mitoxantrone, prednisone)
Number of subjects: 47
Study: 15770198

Group type: EXPERIMENTAL
Intervention: Automated image fusion method for repositioning error detection
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CT scans of patients
Number of subjects: 8
Study: 12458394

Group type: EXPERIMENTAL
Intervention: Insulin-stimulated myocardial glucose uptake measured during hyperinsulinaemic euglycaemic glucose clamp with fluorine‐18 fluorodeoxyglucose.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Insulin-stimulated myocardial glucose uptake and blood flow at rest.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Insulin-stimulated myocardial glucose uptake.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Myocardial glucose uptake and hyperaemic blood flow.
Number of subjects: 20
Study: 10362195

Group type: EXPERIMENTAL
Intervention: Carvedilol (mean dosage 74±23 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metoprolol (mean dosage 142±44 mg/day)
Number of subjects: 30
Study: 7557850

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) alfa therapy
Number of subjects: 141
Study: 2026838

Group type: EXPERIMENTAL
Intervention: Self-teaching booklets
Number of subjects: 161

Group type: COMPARATOR
Intervention: Computer media
Number of subjects: 161

Group type: COMPARATOR
Intervention: Traditional lecture format
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Self-teaching booklet
Number of subjects: 161
Study: 7025260

Group type: EXPERIMENTAL
Intervention: Fenbufen (Cinopal; Lederle) and reduction in training activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reduction in training activity alone
Number of subjects: 0
Study: 30689293

Group type: EXPERIMENTAL
Intervention: Elbow brace during repetitive pitching
Number of subjects: 25

Group type: COMPARATOR
Intervention: No elbow brace (control)
Number of subjects: 25
Study: 27793071

Group type: EXPERIMENTAL
Intervention: Video-games self-training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Traditional self-training
Number of subjects: 24
Study: 27436663

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 676

Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKAs)
Number of subjects: 676
Study: 24315724

Group type: EXPERIMENTAL
Intervention: New oral anticoagulants
Number of subjects: 71683

Group type: EXPERIMENTAL
Intervention: New oral anticoagulants (low-dose)
Number of subjects: 71683
Study: 23130740

Group type: EXPERIMENTAL
Intervention: Palliative care delivered by an existing HIV facility nurse trained to a set standard
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard HIV care alone
Number of subjects: 0
Study: 20674489

Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 18
Study: 17347447

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Tobramycin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (CF patients without stop mutations)
Number of subjects: 29
Study: 16263866

Group type: EXPERIMENTAL
Intervention: PTSD treatment for peacekeepers
Number of subjects: 129

Group type: COMPARATOR
Intervention: PTSD treatment for Vietnam veterans
Number of subjects: 129
Study: 12198002

Group type: EXPERIMENTAL
Intervention: Iron bis-glycine chelate
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Iron bis-glycine chelate (encapsulated in enteric gelatin capsules)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Ferrous sulfate
Number of subjects: 85

Group type: COMPARATOR
Intervention: Heme iron
Number of subjects: 85
Study: 10195718

Group type: EXPERIMENTAL
Intervention: Simple extirpation of the hernial sac (Study A)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Extirpation plus annulorrhaphy (Study A)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Extirpation plus annulorrhaphy (Study B)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Extirpation plus Lichtenstein mesh repair (modified) (Study B)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Cumulative pain scores during coughing and mobilization
Number of subjects: 132
Study: 1592527

Group type: EXPERIMENTAL
Intervention: Intravesical mitomycin C (MMC) with 60-min dwelling time
Number of subjects: 56

Group type: COMPARATOR
Intervention: Intravesical mitomycin C (MMC) with 30-min dwelling time
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Intravesical mitomycin C (MMC)
Number of subjects: 56
Study: 4096193

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia supplemented with nitrous oxide
Number of subjects: 18

Group type: COMPARATOR
Intervention: Total intravenous anesthesia combining fentanyl and continuous infusion of etomidate
Number of subjects: 18
Study: 31479082

Group type: EXPERIMENTAL
Intervention: Subsymptom threshold exercise program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care treatment (control)
Number of subjects: 0
Study: 29975083

Group type: EXPERIMENTAL
Intervention: Recovery-oriented bibliotherapy program (book club)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study: 27105563

Group type: EXPERIMENTAL
Intervention: 2-dose adult formulation
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: 3-dose paediatric formulation
Number of subjects: 209

Group type: COMPARATOR
Intervention: Challenge dose of monovalent vaccine
Number of subjects: 209
Study: 25230081

Group type: EXPERIMENTAL
Intervention: 8.4 mm base curvature (BC) Acuvue Oasys bandage soft contact lens
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: 8.8 mm base curvature (BC) Acuvue Oasys bandage soft contact lens
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Contact lens loss
Number of subjects: 140
Study: 23407285

Group type: EXPERIMENTAL
Intervention: Chlorhexidine application
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional dry care
Number of subjects: 140
Study: 20299247

Group type: EXPERIMENTAL
Intervention: Distraction osteogenesis (DO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional orthognathic surgery (CO)
Number of subjects: 0
Study: 18547300

Group type: EXPERIMENTAL
Intervention: infliximab
Number of subjects: 7931

Group type: EXPERIMENTAL
Intervention: etanercept
Number of subjects: 7931

Group type: EXPERIMENTAL
Intervention: efalizumab
Number of subjects: 7931

Group type: EXPERIMENTAL
Intervention: alefacept
Number of subjects: 7931

Group type: EXPERIMENTAL
Intervention: efalizumab (sensitivity analysis)
Number of subjects: 7931

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7931
Study: 17189547

Group type: EXPERIMENTAL
Intervention: High Glycemic Load (HG) diet
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Low Glycemic Load (LG) diet
Number of subjects: 34

Group type: COMPARATOR
Intervention: Both diets (HG and LG)
Number of subjects: 34
Study: 14581730

Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 46

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study: 10763172

Group type: EXPERIMENTAL
Intervention: Xylometazoline-Dexpanthenol nasal spray
Number of subjects: 61

Group type: COMPARATOR
Intervention: Xylometazoline nasal spray
Number of subjects: 61
Study: 9158632

Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator
Number of subjects: 620
Study: 8427429

Group type: EXPERIMENTAL
Intervention: 0.5 mg nalmefene IV
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: 1.0 mg nalmefene IV
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: nalmefene
Number of subjects: 53
Study: 3478618

Group type: EXPERIMENTAL
Intervention: Prednisone for at least a two-year period
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study: 31744848

Group type: EXPERIMENTAL
Intervention: Population-level interventions for non-communicable diseases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Natural experiments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Practice-based evidence pathway
Number of subjects: 0
Study: 29172732

Group type: EXPERIMENTAL
Intervention: Irbesartan monotherapy
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Trichlormethiazide
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Efonidipine
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Combination therapy (Irbesartan + Trichlormethiazide/Amlodipine/Efonidipine)
Number of subjects: 175
Study: 26648488

Group type: EXPERIMENTAL
Intervention: Active video game intervention (AVGs)
Number of subjects: 21

Group type: COMPARATOR
Intervention: No active video games (control)
Number of subjects: 21
Study: 24596456

Group type: EXPERIMENTAL
Intervention: Tobramycin (80 mg/2 mL)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (2 mL isotonic saline)
Number of subjects: 9
Study: 22954563

Group type: EXPERIMENTAL
Intervention: High-concentration sodium bicarbonate (833 mEq/L, n = 87)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Low-concentration sodium bicarbonate (160 mEq/L, n = 36)
Number of subjects: 123
Study: 20678992

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 18477078

Group type: EXPERIMENTAL
Intervention: Intra-operative natural sound (soft wind and twitter)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No sounds (control group)
Number of subjects: 32
Study: 16178000

Group type: EXPERIMENTAL
Intervention: Pudendal nerve stimulation (PNS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation (SNS)
Number of subjects: 30
Study: 12842170

Group type: EXPERIMENTAL
Intervention: Therapeutically induced weight gain during 11 weeks of re-feeding
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Therapeutically induced weight gain after reaching target weight (11-20 weeks, mean 14.3±3)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Correlation of lg10 leptin levels with BMI increments during re-feeding
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: BMI increments between weeks 7 and 11
Number of subjects: 18
Study: 9886454

Group type: EXPERIMENTAL
Intervention: 1 microg 1alpha(OH)D3 daily (treatment group, n=43)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (control group, n=43)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: 1 microg 1alpha(OH)D3 daily (treatment group)
Number of subjects: 86
Study: 8889259

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (dry powder 20 mg per inhalation and aqueous nasal spray 5.2 mg per dose)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo (matching dry powder and nasal spray)
Number of subjects: 118
Study: 1735336

Group type: EXPERIMENTAL
Intervention: 4 mg loperamide
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 4 mg loperamide oxide
Number of subjects: 12

Group type: COMPARATOR
Intervention: 2 mg loperamide oxide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6084120

Group type: EXPERIMENTAL
Intervention: Guanabenz
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 26
Study: 31729355

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia with neuromuscular blockade
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia with neuromuscular blockade during noxious stimulation
Number of subjects: 81
Study: 29561907

Group type: EXPERIMENTAL
Intervention: Pilates training (12-week programme)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no Pilates training)
Number of subjects: 32
Study: 26758621

Group type: EXPERIMENTAL
Intervention: Family Integrated Care (FICare)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (standard NICU care)
Number of subjects: 6
Study: 25370657

Group type: EXPERIMENTAL
Intervention: Cryoablation iceball in phantom study
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cryoablation iceball in vivo
Number of subjects: 13

Group type: COMPARATOR
Intervention: Comparison of phantom and in vivo findings
Number of subjects: 13
Study: 22323626

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) applied to the superior parietal lobule (SPL) during a spatial short-term memory task.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) applied to the superior parietal lobule (SPL) during a period of passive fixation.
Number of subjects: 0
Study: 19159021

Group type: EXPERIMENTAL
Intervention: Tetracycline solution (100 mg/mL) applied with a microbrush plus scaling and root planing (SRP+T)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Tetracycline solution (100 mg/mL) applied with a microbrush (T)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Saline with a microbrush plus scaling and root planing (SRP+S)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 37
Study: 17844705

Group type: EXPERIMENTAL
Intervention: Atkins diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Commercially available diets (4 groups)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low carbohydrate diet
Number of subjects: 0
Study: 16895678

Group type: EXPERIMENTAL
Intervention: Nephroprotective therapy (blockade of the renin-angiotensin system)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lifestyle measures and pharmacological treatment of metabolic disorders
Number of subjects: 0
Study: 12468166

Group type: EXPERIMENTAL
Intervention: Sertraline (50-100 mg)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 9447852

Group type: EXPERIMENTAL
Intervention: Bispectral index (BIS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Targeted propofol concentration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Measured propofol concentration
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: BIS combined with treatment history
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nitrous oxide
Number of subjects: 20
Study: 7620654

Group type: EXPERIMENTAL
Intervention: Codeine phosphate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ispaghulahusk
Number of subjects: 10
Study: 2228324

Group type: EXPERIMENTAL
Intervention: Theophylline ethylenediamine (2.5 mg/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Theophylline ethylenediamine (5.0 mg/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Theophylline ethylenediamine (7.5 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Standard MCH provocation method
Number of subjects: 9
Study: 55652

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 34

Group type: COMPARATOR
Intervention: D-penicillamine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 30475764

Group type: EXPERIMENTAL
Intervention: SMARRT intervention (personalized, pragmatic, multi-domain Alzheimer's disease risk reduction intervention)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: SMARRT intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Health Education (HE) control
Number of subjects: 200
Study: 28044255

Group type: EXPERIMENTAL
Intervention: Mavoglurant (modified release) as augmentation therapy to SSRIs
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Mavoglurant
Number of subjects: 50
Study: 26203098

Group type: EXPERIMENTAL
Intervention: 200 μg oral iodine daily for 6 months
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 23147964

Group type: EXPERIMENTAL
Intervention: Levocetirizine 5 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fexofenadine 60 mg
Number of subjects: 18
Study: 21718910

Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 6753

Group type: COMPARATOR
Intervention: Type 2 diabetes mellitus (T2DM)
Number of subjects: 6753
Study: 18972723

Group type: EXPERIMENTAL
Intervention: Elongated needle therapy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine acupuncture therapy
Number of subjects: 150
Study: 17057565

Group type: EXPERIMENTAL
Intervention: Physical therapy for neck pain
Number of subjects: 311
Study: 14669965

Group type: EXPERIMENTAL
Intervention: PUFA supplementation (480 mg DHA, 80 mg EPA, 40 mg AA, 96 mg GLA, 24 mg alpha‐tocopheryl acetate)
Number of subjects: 50
Study: 10738049

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 403

Group type: COMPARATOR
Intervention: Sotalol or Propafenone (Control)
Number of subjects: 403
Study: 8874562

Group type: EXPERIMENTAL
Intervention: Warmed intravenous fluids
Number of subjects: 18

Group type: COMPARATOR
Intervention: Room temperature intravenous fluids (Control)
Number of subjects: 18
Study: 1571882

Group type: EXPERIMENTAL
Intervention: Knowledge of risk of anal sex
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Belief in the efficacy of condoms
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Enjoyment of safer sex
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: Substance use
Number of subjects: 612
Study: 6203546

Group type: EXPERIMENTAL
Intervention: Long-acting propranolol (LA, 160 mg once a day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Conventional propranolol (CP, 40 mg four times a day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 10
Study: 31897054

Group type: EXPERIMENTAL
Intervention: Comparative quantitative (CQUANT) format
Number of subjects: 108

Group type: COMPARATOR
Intervention: Noncomparative qualitative (NQUAL) format
Number of subjects: 108

Group type: COMPARATOR
Intervention: Noncomparative quantitative (NQUANT) format
Number of subjects: 108
Study: 30229439

Group type: EXPERIMENTAL
Intervention: Propranolol (2 mg/kg/day) administered during the neovascularization phase of ROP (stage 2)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Physiological saline solution (control group)
Number of subjects: 126
Study: 26853798

Group type: EXPERIMENTAL
Intervention: Non-SLS dentifrice containing enzymes, colostrum, and low concentrations of zinc
Number of subjects: 90

Group type: COMPARATOR
Intervention: SLS-containing dentifrice (Control Group 1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: SLS-containing dentifrice (Control Group 2)
Number of subjects: 90
Study: 25336114

Group type: EXPERIMENTAL
Intervention: Infliximab concentrations > 2.79 μg/mL
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Antibodies to infliximab (ATI) concentrations < 3.15 U/mL
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Infliximab trough concentrations
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Antibodies to infliximab (ATI) concentrations
Number of subjects: 483
Study: 24309401

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg once daily for 15 days
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg once daily for 15 days
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no β‐blocker therapy)
Number of subjects: 55
Study: 22050553

Group type: EXPERIMENTAL
Intervention: 'M' technique massage with carrier oil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 'M' technique massage with mandarin oil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 60
Study: 20509074

Group type: EXPERIMENTAL
Intervention: Literal suggestions (L) such as 'your right arm is heavy'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metaphorical suggestions (M) such as 'your right arm is made of lead'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temporal sequence of suggestions (L followed by M)
Number of subjects: 0
Study: 17158823

Group type: EXPERIMENTAL
Intervention: Radiographic methods in randomised controlled trials
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Standardised procedure for radiographic acquisition
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Quality evaluation of radiographs
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Use of radiographic scores
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Detailing of radiographic assessment
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Reproducibility of reading
Number of subjects: 46
Study: 16314626

Group type: EXPERIMENTAL
Intervention: Cisplatin plus cetuximab (arm A)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Cisplatin plus placebo (arm B)
Number of subjects: 117